My NCBI | Sign In
RSS Settings
  • Search: Drachman DB[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Granzyme B: evidence for a role in the origin of myasthenia gravis.

    Casciola-Rosen L, Miagkov A, Nagaraju K, Askin F, Jacobson L, Rosen A, Drachman DB.

    J Neuroimmunol. 2008 Sep 15;201-202:33-40. Epub 2008 Aug 3.PMID: 18675462 [PubMed - indexed for MEDLINE]Related articles

    2.

    Chapter 8 Therapy of myasthenia gravis.

    Drachman DB.

    Handb Clin Neurol. 2008;91:253-72. No abstract available. PMID: 18631846 [PubMed - in process]Related articles

    3.

    Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis.

    Drachman DB, Adams RN, Hu R, Jones RJ, Brodsky RA.

    Ann N Y Acad Sci. 2008;1132:305-14.PMID: 18567882 [PubMed - indexed for MEDLINE]Related articles

    4.

    Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.

    Krishnan C, Kaplin AI, Brodsky RA, Drachman DB, Jones RJ, Pham DL, Richert ND, Pardo CA, Yousem DM, Hammond E, Quigg M, Trecker C, McArthur JC, Nath A, Greenberg BM, Calabresi PA, Kerr DA.

    Arch Neurol. 2008 Aug;65(8):1044-51. Epub 2008 Jun 9.PMID: 18541787 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Trial of celecoxib in amyotrophic lateral sclerosis.

    Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB.

    Ann Neurol. 2006 Jul;60(1):22-31.PMID: 16802291 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design.

    Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N.

    Muscle Nerve. 2006 Jan;33(1):127-32.PMID: 16258948 [PubMed - indexed for MEDLINE]Related articles

    7.

    Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor.

    Williams MA, Turchan J, Lu Y, Nath A, Drachman DB.

    Exp Brain Res. 2005 Sep;165(3):383-91. Epub 2005 Apr 13.PMID: 15827736 [PubMed - indexed for MEDLINE]Related articles

    8.

    High-dose therapy for autoimmune neurologic diseases.

    Drachman DB, Brodsky RA.

    Curr Opin Oncol. 2005 Mar;17(2):83-8. Review.PMID: 15725909 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gene transfer of baculoviral p35 by adenoviral vector protects human cerebral neurons from apoptosis.

    Miagkov A, Turchan J, Nath A, Drachman DB.

    DNA Cell Biol. 2004 Aug;23(8):496-501.PMID: 15307952 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.

    Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB.

    Muscle Nerve. 2004 Jul;30(1):55-60.PMID: 15221879 [PubMed - indexed for MEDLINE]Related articles

    11.

    Adventures in clinical and basic science.

    Drachman DB.

    J Hematother Stem Cell Res. 2003 Dec;12(6):595-601. No abstract available. PMID: 14977469 [PubMed - indexed for MEDLINE]Related articles

    12.

    Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy.

    Drachman DB, Wu JM, Miagkov A, Williams MA, Adams RN, Wu B.

    Ann N Y Acad Sci. 2003 Sep;998:520-32.PMID: 14592923 [PubMed - indexed for MEDLINE]Related articles

    13.

    Production and characterization of a T cell receptor transgenic mouse recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.

    Miagkov A, Lobito AA, Yang B, Lopes MF, Adams RN, Palardy GR, Johnson MM, McFarland H, Lenardo MJ, Drachman DB.

    Ann N Y Acad Sci. 2003 Sep;998:379-83. No abstract available. PMID: 14592900 [PubMed - indexed for MEDLINE]Related articles

    14.

    Autonomic "myasthenia": the case for an autoimmune pathogenesis.

    Drachman DB.

    J Clin Invest. 2003 Mar;111(6):797-9. No abstract available. PMID: 12639983 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide.

    Drachman DB, Jones RJ, Brodsky RA.

    Ann Neurol. 2003 Jan;53(1):29-34.PMID: 12509845 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.

    Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, Rothstein JD.

    Ann Neurol. 2002 Dec;52(6):771-8.PMID: 12447931 [PubMed - indexed for MEDLINE]Related articles

    17.

    T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.

    Lobito AA, Yang B, Lopes MF, Miagkov A, Adams RN, Palardy GR, Johnson MM, McFarland HI, Recher M, Drachman DB, Lenardo MJ.

    Eur J Immunol. 2002 Jul;32(7):2055-67.PMID: 12115627 [PubMed - indexed for MEDLINE]Related articles

    18.

    Myasthenia gravis.

    Vincent A, Drachman DB.

    Adv Neurol. 2002;88:159-88. Review. No abstract available. PMID: 11908224 [PubMed - indexed for MEDLINE]Related articles

    19.

    Specific immunotherapy of experimental myasthenia gravis in vitro: the "guided missile" strategy.

    Wu JM, Wu B, Miagkov A, Adams RN, Drachman DB.

    Cell Immunol. 2001 Mar 15;208(2):137-47.PMID: 11333146 [PubMed - indexed for MEDLINE]Related articles

    20.

    Specific immunotherapy by genetically engineered APCs: the "guided missile" strategy.

    Wu B, Wu JM, Miagkov A, Adams RN, Levitsky HI, Drachman DB.

    J Immunol. 2001 Apr 1;166(7):4773-9.PMID: 11254740 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    14 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity